Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Eli Lilly And Co (LLY) vs Teucrium Wheat Fund (WEAT) Price & Performance

Eli Lilly And CoTrade
Teucrium Wheat FundTrade

Price performance (Past 24H)

Key statistics

Eli Lilly And Co vs Teucrium Wheat Fund — how do they compare? Eli Lilly And Co trades at $1,220.55 (market cap $1.08T), while Teucrium Wheat Fund trades at $24.39. The key difference: Eli Lilly And Co pays a 0.57% dividend while Teucrium Wheat Fund pays none. Which is the better fit depends on your goals.

LLYWEAT
Market Cap
$1.08T
Sector
HealthCommodities - Metals/Agriculture
52-Week High
$1.24K$26.00
52-Week Low
$639.43$19.88
Enterprise Value
$1.13T
Dividend Yield
0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,223.97, down 0.62% on the day, maintaining strong bullish momentum with consecutive earnings beats and robust revenue growth. The stock shows technical strength above key support levels at $1,207, while fundamentals reveal exceptional profitability with 33.53% net margins and 102.44% ROE. Recent quarterly results exceeded expectations, with Q2 2026 revenue surging 48% to $23 billion driven by Mounjaro and Zepbound demand.

Outlook remains positive with analyst consensus targeting $1,380 and 73% buy ratings, though elevated valuations (P/E 40.8) and regulatory risks around weight-loss drug competition present headwinds. The company's pipeline advancement with retatrutide filing expected in 2027 provides medium-term growth catalysts, but investors should monitor execution risks in the competitive obesity drug market.

Teucrium Wheat Fund

WEAT, the Teucrium Wheat Fund, trades at $24.42, up 1.71% today, with a bullish technical signal from moving averages. Recent news highlights a 9.9% monthly gain, driven by wheat price increases and USDA production cuts. The ETF's performance is closely tied to agricultural commodity markets and inflation trends.

Outlook remains influenced by supply dynamics and inflation; opportunities exist from sustained commodity strength, but risks include weather volatility and economic shifts that could pressure wheat prices and ETF returns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY

About Teucrium Wheat Fund

WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.

Read more on WEAT